Name | 3-[Bis(4-fluorophenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane hydrochloride (1:1) |
---|---|
Synonyms |
8-Azabicyclo[3.2.1]octane, 3-[bis(4-fluorophenyl)methoxy]-8-methyl-, hydrochloride (1:1)
3-[Bis(4-fluorophenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane hydrochloride (1:1) |
Description | AHN 1-055 hydrochloride is a dopamine uptake inhibitor, with an IC50 of 71 nM. AHN 1-055 hydrochloride binds with high affinity to the dopamine transporter (DAT) and may serve as leads for the development of agentia to treat cocaine abuse[1]. |
---|---|
Related Catalog | |
Target |
IC50: 71 nM (dopamine uptake)[1] |
In Vivo | AHN 1-055 (5 mg/kg; i.v.) inhibits the uptaking of brain dopamine with an IC50 of 311.8 ng/ml in vivo[1]. AHN 1-055 (10 mg/kg; i.v.) exhibits Cmax of 1.48 mg/L and terminal elimination half-lives of 7.69 h due to 1.8L/h/kg plasma clearance combined with 18.7 L/kg volumes of distribution[1]. Animal Model: Adult male Sprague Dawley rats (250-275 g)[1] Dosage: 5 mg/kg (Pharmacokinetic Analysis) Administration: I.v. administration Result: Cmax (1.48 mg/L); T1/2 (7.69 h). |
References |
Molecular Formula | C21H24ClF2NO |
---|---|
Molecular Weight | 379.871 |
Exact Mass | 379.151459 |